These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29526116)

  • 1. Menopausal hormone therapy: a better and safer future.
    Davey DA
    Climacteric; 2018 Oct; 21(5):454-461. PubMed ID: 29526116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
    L'Hermite M
    Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone or progestin as menopausal ovarian hormone therapy: recent physiology-based clinical evidence.
    Prior JC
    Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):495-501. PubMed ID: 26512775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel intrauterine system for endometrial protection.
    Sturdee D
    J Br Menopause Soc; 2006 Mar; 12 Suppl 1():1-3. PubMed ID: 16513011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of micronized progesterone on the endometrium: a systematic review.
    Stute P; Neulen J; Wildt L
    Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review.
    Depypere H; Inki P
    Climacteric; 2015; 18(4):470-82. PubMed ID: 25553775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in hormone replacement therapy.
    Khashoggi TY
    Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia.
    Ewies AA; Alfhaily F
    Obstet Gynecol Surv; 2012 Nov; 67(11):726-33. PubMed ID: 23151756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone and endometrial cancer.
    Gompel A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal replacement regimens and bleeding.
    Dören M
    Maturitas; 2000 Jan; 34 Suppl 1():S17-23. PubMed ID: 10759060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of micronized progesterone on breast cancer risk: a systematic review.
    Stute P; Wildt L; Neulen J
    Climacteric; 2018 Apr; 21(2):111-122. PubMed ID: 29384406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.
    Graham S; Archer DF; Simon JA; Ohleth KM; Bernick B
    Gynecol Endocrinol; 2022 Nov; 38(11):891-910. PubMed ID: 36075250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.